SOUTH SAN FRANCISCO, Calif. (AP) — Calithera Biosciences Inc. (CALA) on Thursday reported a loss of $11 million in its fourth quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 31 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.
The drug developer posted revenue of $7.3 million in the period.
For the year, the company reported that its loss narrowed to $27.8 million, or 84 cents per share. Revenue was reported as $26 million.
Calithera shares have increased slightly more than 8 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.05, a drop of 25 percent in the last 12 months.